Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.58

+1.8%

Nov 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (2857)	6/1/2010 4:06:48 PM
From: Jibacoa	Read Replies (2) of 3722

After closing above $3 NBIX had no problem on going over its April and even its Sep Hs. It seems that it wants to continue its UT without closing its May 25 UG.<g> bigcharts.marketwatch.com As previously mentioned, the open label extension portion of the Elagolix trial is proceeding well, it seems to have good potential for treatment of dysmenorrhea in patients with endometriosis, and NBIX made some comments on it as expected.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next